TrialPloS one2015

The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients.

Owen Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.